CIK 0001479419
- Non-accelerated filer
- Smaller reporting company
KALA BIO, Inc.
Sign in to watch- Ticker
- KALA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 270604595
- Phone
- +1 781-996-5252
- Business address
- 1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
- Former names
- KALA BIO, Inc., Kala Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-23 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −967 | $0.82 | $793 | 28,906 |
| 2025-10-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −32,230 | $0.83 | $27K | 29,873 |
| 2025-06-24 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −3,631 | $4.01 | $15K | 62,100 |
| 2025-06-03 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −2,850 | $3.74 | $11K | 65,731 |
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +10,100 | 70,287 | ||
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −1,706 | $7.63 | $13K | 68,581 |
| 2025-01-06 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +45,200 | 45,200 | ||
| 2024-06-26 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −4,163 | $4.75 | $20K | 60,187 |
| 2024-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −1,786 | $6.09 | $11K | 64,350 |
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +4,600 | 67,363 | ||
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Sale | −1,227 | $6.74 | $8K | 66,136 |
| 2024-01-04 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +20,500 | 20,500 | ||
| 2023-06-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +36,144 | 62,763 | ||
| 2023-06-22 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (right to buy) | +48,192 | 48,192 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Grant or award | +14,736 | 26,619 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −1,841 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −578 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −1,399 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −2,999 | 0 | ||
| 2023-05-31 | Reumuth Mary CHIEF FINANCIAL OFFICER | Returned to the company · Stock Option (right to buy) | −2,399 | 0 |
Page 1 of 3 · 46 trades